Primary experimental results of methylseleninic acid on the proliferation inhibition and apoptotic induction in human high-metastatic large cell lung cancer cell line L9981

Chinese Journal of Lung Cancer

Volumn 9, Issue 2, 2006, Pages 103-108

  Liu, Jiewei ^a   Zhong, Xiaorong ^a   Zhou, Qing Hua ^a   Gao, Allen C ^b   Wang, Yanping ^a   Zhu, Wen ^a   Ma, Li ^a   Zhang, Zhixuan ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Apoptosis; Growth inhibition; Human high metastatic large cell lung cancer line L9981; Methylseleninic acid

Indexed keywords

FAS ANTIGEN; FAS LIGAND; METHYLSELENINIC ACID; PROTEIN BAX; PROTEIN P21; PROTEIN P53; SELENIOUS ACID; TRYPAN BLUE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LUNG CANCER; LUNG METASTASIS; PROTEIN EXPRESSION; UPREGULATION;

EID: 33646244729     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 1996, 276(24): 1957-1563.
2. Erratum in: JAMA, 1997, 277(19): 1520.
3. Whanger PD. Selenium and its relationship to cancer; an update dagger. Br J Nutr, 2004, 91(1): 11-28.
4. Ip C, Thompson HJ, Zhu Z, et al. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 2000, 60(11):2882-2886.
5. Abdulah R, Miyazaki K, Nakazawa M, et al. Chemical forms of selenium for cancer prevention. J Trace Elem Med Biol, 2005, 19 (2-3): 141-150.
6. Huang HH, Su M. Advances in the study on selenium and its chemoprevention and mechanisms of anti-carcinogenic effect. J Envir Occupa Med, 2003, 20(3): 242-245.
7. Dong Y, Zhang H, Hawthorn L, et al. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res, 2003, 63(1): 52-59.
8. Sinha R, Unni E, Ganther HE, et al. Methylseleninic acid, a potent growth inhibitor of synchronized mouse mammary epithelial tumor cells in vitro. Biochem Pharmacol, 2001, 61(3): 311-317.
9. Zhu Z, Jiang W, Ganther HE, et al. Mechanisms of cell cycle arrest by methylseleninic acid. Cancer Res, 2002, 62(1): 156-164.
10. Swede H, Dong Y, Reid M, et al. Cell cycle arrest biomarkers in human lung cancer cells after treatment with selenium in culture. Cancer Epidemiol Biomarkers Prev, 2003, 12(11 Pt 1): 1248-1252.
11. Zhou QH, Wang YP, Che GW, et al. Establishment and their biological characteristics of clonal cell subpopulations (NL9980 and L9981) from a human lung large cell carcinoma cell line (WCQH9801). Chin J Lung Cancer, 2003, 6(6): 464-468.
12. EI-Bayoumy K, Sinha R. Molecular chemoprevention by selenium: A genomic approach. Mutat Res. 2005, 591(1-2): 224-236.
13. Jiang C, Wang Z, Ganther H, et al. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res, 2001, 61(7): 3062-3070.
14. Hu H, Jiang C, Ip C, et al. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells. Clin Cancer Res, 2005, 11(6): 2379-2388.
15. Zu K, Ip C. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res, 2003, 63(20): 6988-6995.
16. Dong Y, Lee SO, Zhang H, et al. Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res, 2004, 64(1): 19-22.
17. Dong Y, Zhang H, Gao AC, et al. Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers. Mol Cancer Ther, 2005, 4(7): 1047-1055.
18. Cho SD, Jiang C, Malewicz B, et al. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Mol Cancer Ther, 2004, 3(5): 605-611.
19. Lee SO, Nadiminty N, Wu XX, et al. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Cancer Res, 2005, 65(8): 3487-3492.
20. Shah YM, Al-Dhaheri M, Dong Y, et al. Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells. Mol Cancer Ther, 2005, 4(8): 1239-1249.
21. Shah YM, Kaul A, Dong Y, et al. Attenuation of estrogen receptor alpha (ERalpha) signaling by selenium in breast cancer cells via downregulation of ERalpha gene expression. Breast Cancer Res Treat, 2005, 92(3): 239-250.
22. Ganther H, Ip C. Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro. J Nutr, 2001, 131(2): 301-304.
23. Liu S, Shia D, Liu G, et al. Roles of Se and NO in apoptosis of hepatoma cells. Life Sci, 2000, 68(6): 603-610.
24. El-Bayoumy K, Narayanan BA, Desai DH, et al. Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray. Carcinogenesis, 2003, 24(9): 1505-1514.
25. Zhu MX, Zhang JS, Yang ZH, et al. Nanoselenium prevents lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in kunming mice. Chin J Cancer, 2000, 19(10): 883-886.
26. Cheng DS, Deng YP, Lu XY. Effect of selenium supplementation on transplantive tumor growth and lymphocyte functions in mice. Acta Univ Sci Med Chongqing, 2000, 25(1): 41-43.